XML 53 R36.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of segment net loss and significant segment expenses
The following table presents the segment net loss and significant segment expenses for the years ended December 31, 2024, and 2023 (in thousands):
 
    
Year Ended

December 31,
 
    
2024
    
2023
 
Employee-related expenses:
     
Research and development employee-related expenses
   $ 11,135      $ 10,351  
General and administrative employee-related expenses
     5,553        3,240  
External research and development expenses:
     
Research and
pre-clinical
expenses
     8,477        8,321  
Clinical and development expenses
     15,380        7,202  
Chemistry, manufacturing, and control expenses
     3,570        8,947  
Non employee-related general and administrative expenses
     8,733        3,988  
Other segment items
1
     5,134        774  
  
 
 
    
 
 
 
Net loss
   $ 57,982      $ 42,823